Insider Purchases: Inside the Buy

Tag: High Growth Stocks

Illustration of a giant Eli Lilly pill capsule spilling cash, rising stock charts, and drug bottles, symbolizing blockbuster earnings, insider buying, and growth momentum.

Elite Buys Ely: Should You Buy Lilly’s Stock Too?

Eli Lilly insiders are opening their wallets after the company crushed Q2 2025 — revenue up 38%, EPS up 92%, and blockbuster drugs Zepbound and Mounjaro fueling a raised guidance. Institutions are all-in, the pipeline is buzzing, but the valuation is sky-high. Is LLY worth chasing at $639, or is patience the better prescription?

Read entire article

Tags: Biopharma, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, Eli Lilly, Eli Lilly vs Novo Nordisk, Funanc1al Insider Series, Funanc1al Stocks to Watch, Funanc1alBiotech, Funanc1alEdge, Funanc1alFun, Funanc1alHumor, Funanc1alInsiderSeries, Funanc1alInsights, Funanc1alInvesting, Funanc1alPharma, Funanc1alStocks, Healthcare Stocks, High Growth Stocks, Insider Buying, Institutional Ownership, LLY, Mounjaro, Obesity Drugs, Orforglipron, Pharmaceutical Earnings, Zepbound
Cartoon-style digital illustration of a modern-day Robin Hood with fintech gadgets in hand, riding a rocket labeled

Can Robinhood Still Steal the Show?

Robinhood’s got a new backer — and it’s no amateur. Christopher Payne (ex-DoorDash, Tinder, eBay) just went all in with a bold $2M+ insider buy. Add in huge crypto growth, a string of acquisitions, and global ambitions… and suddenly Robinhood doesn’t just look ready — it looks legendary. Is $HOOD still a buy? Let’s break it down.

Read entire article

Tags: Christopher Payne, Crypto Trading, Direc, DIrector Buying, Director Insider Buying, DoorDash, Fintech Stocks, Funanc1al Insider Series, Funanc1alFinance, Funanc1alInsiderSeries, Growth Stocks, High Growth Stocks, HOOD, HOOD Stock, insider buying, Insider Buys, Insider Purchases, InsiderActivity, InsiderBuy, InsiderPurchases, InsiderScoops, Investment Ideas, Robinhood, Robinhood Stock, Stock Market Humor, Stock Tips, Tech Stocks
Tesla’s Q1 wasn’t pretty — but billionaire insider buys, booming energy growth, and AI dreams are setting the stage for a comeback. Should you buckle up or bail out? We break it down, Funanc1al-style. 🚗⚡📈

Tesla (TSLA): A Bumpy Quarter, a Billionaire Buy, and the Usual Muskian Mayhem

Tesla's Q1 numbers stumbled, but billionaires are buying and energy growth is sizzling. 🌋 Is TSLA ready for a rerating, or just revving its engines? We dissect the Muskian mayhem — with laughs and icons, of course. 🚗⚡

Read entire article

Tags: At the Confluence of Three Industries, Auto Tech Energy Play, Elon Musk, Energy Powerhouse, EV Stocks, Funanc1al Investing, Growth Stocks, High Growth Stocks, Joseph Gebbia, Tech and Energy Powerhouse, Tesla AI, Tesla Energy, Tesla Stock, TSLA, Value Trap or Tech Titan?